Trisomy 11 as an additional chromosome alteration in a child with acute promyelocytic leukemia with poor prognosis.

about

Microgranular variant of acute promyelocytic leukemia with der(17) ins(17;15): A case report and review of the literature

P2860

Q33428004-8104B8C8-8C7F-45F9-BB7C-E858A0FCDA37

P2860

Trisomy 11 as an additional chromosome alteration in a child with acute promyelocytic leukemia with poor prognosis.

Item

http://www.wikidata.org/entity/Q36248003

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Trisomy 11 as an additional ch ...... leukemia with poor prognosis.

@ast

Trisomy 11 as an additional ch ...... leukemia with poor prognosis.

@en

type

Item

label

Trisomy 11 as an additional ch ...... leukemia with poor prognosis.

@ast

Trisomy 11 as an additional ch ...... leukemia with poor prognosis.

@en

prefLabel

Trisomy 11 as an additional ch ...... leukemia with poor prognosis.

@ast

Trisomy 11 as an additional ch ...... leukemia with poor prognosis.

@en

P1476

Trisomy 11 as an additional ch ...... leukemia with poor prognosis.

@en

P2093

Elenice Ferreira Bastos

http://www.w3.org/2001/XMLSchema#string

Glicínia Pimenta

http://www.w3.org/2001/XMLSchema#string

Lidiane Alice Silva

http://www.w3.org/2001/XMLSchema#string

Marcelo Coelho Ramos

http://www.w3.org/2001/XMLSchema#string

Paulo Ivo Cortez

http://www.w3.org/2001/XMLSchema#string

Stella Beatriz Gonçalves de Lucena

http://www.w3.org/2001/XMLSchema#string

Teresa de Souza Fernandez

http://www.w3.org/2001/XMLSchema#string

P2860

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.

Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.

Trisomy 11: an association with stem/progenitor cell immunophenotype.

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

P304

659016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/659016

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232278874

http://www.w3.org/2001/XMLSchema#string

P698

23074691

http://www.w3.org/2001/XMLSchema#string

P932

3447222

http://www.w3.org/2001/XMLSchema#string

Trisomy 11 as an additional chromosome alteration in a child with acute promyelocytic leukemia with poor prognosis.

about

P2860

P2860

Trisomy 11 as an additional chromosome alteration in a child with acute promyelocytic leukemia with poor prognosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932